CS
SIOX

Credit Suisse’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Credit Suisse’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,938
Closed -$327K – 4257
2017
Q3 		$327K Buy
+5,938
New +$1M ﹤0.01% 3699

Other funds holding SIOX

SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Credit Suisse's SIOX Position: Q3 2019 in Review

Credit Suisse sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q3 2019, closing a stake of 58,085 shares — an estimated $362K sold.

Credit Suisse first reported a position in SIOX in Q3 2015 and held it in 10 quarters. The position peaked at $477K in Q3 2015. 48 funds tracked by Wall St. Rank hold SIOX as of Q3 2019.

  • Credit Suisse reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Credit Suisse sold 58,085 Sio Gene Therapies Inc. Common Stock shares in Q3 2019, an estimated $362K.
  • Credit Suisse first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2015 and held it in 10 quarters.
  • Credit Suisse's Sio Gene Therapies Inc. Common Stock position peaked at $477K in Q3 2015.
  • 48 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q3 2019.

Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.